Brachy Therapy Devices Market Scope And Analysis

Report Code : TIPHE100001169
Category : Life Sciences

No. of Pages : 150

Buy Now

Brachytherapy Devices Market Analysis, Scope, and Growth by 2030

Buy Now

Brachytherapy Devices Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 310.96 Million
Market Size by 2030	US$ 501.75 Million
Global CAGR (2022 - 2030)	6.2%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Product Type Seeds Brachytherapy Afterloaders and Applicators Electronic Brachytherapy By Type High-Dose Rate Brachytherapy Implant and Low-Dose Rate Brachytherapy Implant By Application Breast Cancer Cervical Cancer Prostate Cancer Lung Cancer By End User Hospitals and Specialty Clinics Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Elekta Varian Medical Systems Inc BEBIG Medical Theragenics Corporation IsoAid Siemens Healthineers AG BXTA BD Eckert and Ziegler

Industry Developments and Future Opportunities:

The brachytherapy devices market forecast can help stakeholders in this marketplace plan their growth strategies. As per company press releases, a few strategic developments by leading players operating in the global market are listed below:

In October 2023, Elekta announced acquisition of the Xoft business from iCAD, Inc. through an asset acquisition. By acquiring the Xoft Axxent Electronic Brachytherapy (eBx) System, along with the transfer of employees, the company aims to provide an expanded range of cancer treatment options and electronic brachytherapy technology.
As per the press release in July 2023, CIVCO Radiotherapy announced its partnership with Qfix, a company that provides devices for positioning and immobilizing patients, during the American Society for Radiation Oncology (ASTRO) Annual Meeting held from October 23–26, 2022 in San Antonio, Texas.
In July 2022, BEBIG Medical acquired Wolf-Medizintechnik GmbH (WOmed), a German company that supplies cutting-edge X-ray therapy and newly developed intraoperative radiation therapy products to the global market. The acquisition aimed to expand BEBIG Medical's product portfolio in radiation therapy for cancer treatment.
In December 2020, Varian Medical Systems, Inc, launched four new brachytherapy applicator sets for HDR brachytherapy of vagina, cervix, uterus, endometrium, and rectum. The new suite of applicators is designed to address issues of applicator size, ease of use, and MRI imaging support. This new addition is made more user-friendly and comfortable for patients, allowing clinicians to treat more patients on an outpatient basis.

Elekta; Varian Medical Systems, Inc.; BEBIG Medical; Theragenics Corporation; IsoAid; Siemens Healthineers AG; BXTA; BD; Eckert and Ziegler; and Perspective Therapeutics are some of the key companies profiled in the brachytherapy devices market report. These leading players focus on expanding and diversifying their market presence and clientele, tapping business opportunities in the market.